N.J. lawmakers pass bill to ban flavored vaping products

N.J. lawmakers pass bill to ban flavored vaping products

A bill that would ban the sale of flavored vaping products was passed Monday by New Jersey lawmakers. The bill —which forbids the sale and distribution of vaping products with a "distinguishable flavor, taste, or aroma" and is meant to protect children—was passed in the Senate and State Assembly. It now goes to Gov. Phil Murphy, CBS News reported. If Murphy signs the bill into law, it would take effect 90 days later. Last year, Murphy set up a task force that recommended a ban on flavored vaping products . The task force presented its recommendations in October, just two days after the state's first vaping-related death was reported. At the time, Murphy agreed with the task force 's findings, CBS News reported. "Without question, I would take more forceful executive action today if I had the authority," Murphy said in October. "But ultimately, many of these recommendations need to be taken up by the legislature." Explore further More information: CBS News Article Copyright © 2020 HealthDay . All rights reserved. Citation : N.J. lawmakers pass bill to ban flavored vaping products (2020, January 15) retrieved 15 January 2020 from https://medicalxpress.com/news/2020-01-nj-lawmakers-bill-flavored-vaping.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More